Webinar recording
Sensitive high-throughput plasma proteomics

About this webinar

Identifying early markers of transitions between human health and disease is a key objective of systems medicine. The strategy involves collecting diverse longitudinal data for each individual, before and after symptoms manifest. This deep phenotyping is made possible by a range of technologies, including proteomics. However, until recently, a rate-limiting step was the collection of comprehensive plasma proteomics.

Watch this webinar to learn how this bottleneck has been removed using high-throughput and high-sensitivity protein profiling with Olink® technology coupled with SPT Labtech's liquid handling automation.

Key learning objectives:

• Learn how longitudinal deep phenotyping, including plasma proteomics, is central to systems medicine, the study of complex diseases, and biomarker discovery.
• Find out the importance of establishing baseline measurements and reference ranges for normal human plasma, which can also signal outliers in undiagnosed disease.
• Discover how potential prognostic markers of severe and "long" COVID-19 were identified in the plasma proteome.
• Learn how adopting an Olink and SPT Labtech bundled infrastructure can deliver high throughput and uncompromised data quality for genomics, single-cell, RNA seq and much more.